ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.518,03
-0,44%
S&P 500
5.667,20
0,64%
Dow Jones
40.954,48
1,85%
Euro vs US Dollar
1,09009
0,01%
Bitcoin
64.799,81
-0,08%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Cellectar Biosciences Inc (CLRBW)

  7. Cellectar Biosciences Inc (CLRBW) News

CLRBW

Cellectar Biosciences (CLRBW)

Cellectar Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CLRBW
DatumZeitQuelleÜberschriftSymbolFirma
08/08/201614h30GlobeNewswire Inc.Cellectar Biosciences to Host Conference Call on August 15 to Report Second Quarter 2016 Financial Results and Corporate Perf...NASDAQ:CLRBWCellectar Biosciences Inc
03/08/201614h00GlobeNewswire Inc.Cellectar Biosciences Announces $2 Million NCI SBIR Contract for a Phase 2 Clinical StudyNASDAQ:CLRBWCellectar Biosciences Inc
20/07/201614h30GlobeNewswire Inc.Cellectar Biosciences Appoints Jarrod Longcor Senior Vice President of Corporate Development and OperationsNASDAQ:CLRBWCellectar Biosciences Inc
23/06/201614h30GlobeNewswire Inc.Cellectar Biosciences Announces Results of NCI-Sponsored Study of CLR 125 Showing Potential Effect Against Triple Negative Br...NASDAQ:CLRBWCellectar Biosciences Inc
15/06/201614h30GlobeNewswire Inc.Cellectar Biosciences Announces Results of In Vivo Study Demonstrating PDC Platform Delivery of Paclitaxel to be Superior in ...NASDAQ:CLRBWCellectar Biosciences Inc
31/05/201614h30GlobeNewswire Inc.Cellectar Biosciences Announces USPTO Issues Patent for its Radiotherapeutic PDC Portfolio, Further Strengthening and Expandi...NASDAQ:CLRBWCellectar Biosciences Inc
25/05/201614h30GlobeNewswire Inc.Cellectar Biosciences Announces USPTO Issues Patent for New Phospholipid Drug Conjugate (PDC) with PaclitaxelNASDAQ:CLRBWCellectar Biosciences Inc
24/05/201614h30GlobeNewswire Inc.Cellectar Biosciences to Present at the 5th Annual SeeThru Equity Microcap Investor ConferenceNASDAQ:CLRBWCellectar Biosciences Inc
23/05/201614h30GlobeNewswire Inc.Cellectar Biosciences to Present at the 2016 Marcum MicroCap ConferenceNASDAQ:CLRBWCellectar Biosciences Inc
20/05/201614h30GlobeNewswire Inc.Cellectar Biosciences Patent Application for Phospholipid-Ether Analogs as Cancer Targeting Drug Vehicles Published by USPTONASDAQ:CLRBWCellectar Biosciences Inc
16/05/201622h05GlobeNewswire Inc.Cellectar Biosciences Satisfies All Nasdaq Listing CriteriaNASDAQ:CLRBWCellectar Biosciences Inc
12/05/201622h15GlobeNewswire Inc.Cellectar Biosciences Announces First Quarter 2016 Financial ResultsNASDAQ:CLRBWCellectar Biosciences Inc
04/05/201614h30GlobeNewswire Inc.Cellectar Biosciences to Host Conference Call on May 12, 2016 to Report First Quarter 2016 Financial Results and Provide a Co...NASDAQ:CLRBWCellectar Biosciences Inc
20/04/201616h48GlobeNewswire Inc.Cellectar Biosciences Announces Successful Completion of $8 Million Public OfferingNASDAQ:CLRBWCellectar Biosciences Inc
15/04/201614h30GlobeNewswire Inc.Cellectar Biosciences Announces Pricing of $7,000,000 Public OfferingNASDAQ:CLRBWCellectar Biosciences Inc
07/04/201614h30GlobeNewswire Inc.Cellectar Biosciences Receives Positive NASDAQ Listing DeterminationNASDAQ:CLRBWCellectar Biosciences Inc
10/03/201622h15GlobeNewswire Inc.Cellectar Biosciences Announces Year End 2015 Financial ResultsNASDAQ:CLRBWCellectar Biosciences Inc
10/03/201601h46GlobeNewswire Inc.Cellectar Biosciences to Present at the 28th Annual Roth Capital ConferenceNASDAQ:CLRBWCellectar Biosciences Inc
10/03/201601h46GlobeNewswire Inc.Cellectar Biosciences to Host Conference Call on March 10 to Report Year End 2015 Financials, Corporate Performance and 2016 ...NASDAQ:CLRBWCellectar Biosciences Inc
10/03/201601h46GlobeNewswire Inc.Cellectar Biosciences Announces 1-for-10 Reverse Stock SplitNASDAQ:CLRBWCellectar Biosciences Inc
07/01/201614h30GlobeNewswire Inc.Cellectar Biosciences to Present at the 2016 Biotech ShowcaseNASDAQ:CLRBWCellectar Biosciences Inc
05/01/201614h30GlobeNewswire Inc.Cellectar Biosciences Announces Positive Data From Phase 1 Therapeutic Trial of CLR 131 in Multiple MyelomaNASDAQ:CLRBWCellectar Biosciences Inc
16/12/201514h30GlobeNewswire Inc.Cellectar Biosciences and Pierre Fabre Laboratories Announce Oncology Research CollaborationNASDAQ:CLRBWCellectar Biosciences Inc
09/12/201514h30GlobeNewswire Inc.Cellectar Biosciences to Provide Update on Phase 1 Multiple Myeloma StudyNASDAQ:CLRBWCellectar Biosciences Inc
20/11/201514h30GlobeNewswire Inc.Cellectar Biosciences Chief Scientific Officer Receives International Recognition for Pioneering ResearchNASDAQ:CLRBWCellectar Biosciences Inc
12/11/201522h45GlobeNewswire Inc.Cellectar Biosciences Announces Third Quarter Financial ResultsNASDAQ:CLRBWCellectar Biosciences Inc
10/11/201514h30GlobeNewswire Inc.Cellectar Biosciences Converts Patent Application for Phospholipid-Ether Analogs as Cancer Targeting Drug VehiclesNASDAQ:CLRBWCellectar Biosciences Inc
05/11/201514h30GlobeNewswire Inc.Cellectar Biosciences to Host Conference Call on November 12th to Discuss Third Quarter Financial Results and Provide Clinica...NASDAQ:CLRBWCellectar Biosciences Inc
02/11/201514h30GlobeNewswire Inc.Cellectar Biosciences Provides Phospholipid Drug Conjugate (PDC) Platform Development UpdateNASDAQ:CLRBWCellectar Biosciences Inc
16/10/201514h30GlobeNewswire Inc.Cellectar Biosciences to Present at the 2015 BIO Investor ForumNASDAQ:CLRBWCellectar Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CLRBW

Kürzlich von Ihnen besucht

TG
ALV
Allianz
TG
DTE
Deutsche Telekom
DBI
SDXP
SDAX
TG
BAS
BASF
AMEX
XLF
Financial Select Sector
TG
D7G
Nel ASA
NASDAQ
NVDA
NVIDIA
NASDAQ
AAPL
Apple
FX
EURJPY
Euro vs Yen
CCOM
US100
US Tech 100
COIN
SOLUSD
Solana
NASDAQ
TSLA
Tesla
DBI
TDXP
Tec DAX
NYSE
MCD
McDonalds
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten